These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors. Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133 [TBL] [Abstract][Full Text] [Related]
45. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors. Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217 [TBL] [Abstract][Full Text] [Related]
46. Potential target identification for breast cancer and screening of small molecule inhibitors: A bioinformatics approach. Agarwal S; Kashaw SK J Biomol Struct Dyn; 2021 Apr; 39(6):1975-1989. PubMed ID: 32186248 [TBL] [Abstract][Full Text] [Related]
47. Pharmacophore-based virtual screening and Roney M; Huq AKMM; Issahaku AR; Soliman MES; Hossain MS; Mustafa AH; Islam MA; Dubey A; Tufail A; Mohd Aluwi MFF; Tajuddin SN J Biomol Struct Dyn; 2023; 41(21):12186-12203. PubMed ID: 36645141 [TBL] [Abstract][Full Text] [Related]
48. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models. Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122 [TBL] [Abstract][Full Text] [Related]
49. Discovery of new human epidermal growth factor receptor-2 (HER2) inhibitors for potential use as anticancer agents via ligand-based pharmacophore modeling. Zalloum H; Tayyem R; Irmaileh BA; Bustanji Y; Zihlif M; Mohammad M; Rjai TA; Mubarak MS J Mol Graph Model; 2015 Sep; 61():61-84. PubMed ID: 26188796 [TBL] [Abstract][Full Text] [Related]
50. Identification of naphthyridine and quinoline derivatives as potential Nsp16-Nsp10 inhibitors: a pharmacoinformatics study. Aldahham BJM; Al-Khafaji K; Saleh MY; Abdelhakem AM; Alanazi AM; Islam MA J Biomol Struct Dyn; 2022 Jun; 40(9):3899-3906. PubMed ID: 33252031 [TBL] [Abstract][Full Text] [Related]
51. Exploring EGFR inhibitors with the aid of virtual screening, docking, and dynamics simulation studies. Rehman ZU; Najmi A J Biomol Struct Dyn; 2024; 42(19):10489-10509. PubMed ID: 37707987 [TBL] [Abstract][Full Text] [Related]
57. On the search for COVID-19 therapeutics: identification of potential SARS-CoV-2 main protease inhibitors by virtual screening, pharmacophore modeling and molecular dynamics. Hassan A; Arafa RK J Biomol Struct Dyn; 2022 Oct; 40(17):7815-7828. PubMed ID: 33749545 [TBL] [Abstract][Full Text] [Related]
58. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation. Wu M; Han J; Liu Z; Zhang Y; Huang C; Li J; Li Z Life Sci; 2020 Oct; 258():118228. PubMed ID: 32781071 [TBL] [Abstract][Full Text] [Related]
60. Discovery of potential inhibitors for stat3: ligand based 3D pharmacophore, virtual screening, molecular docking, dynamic studies and Lakshmanan K; T K P; K Pai SR; Rajagopal K; Byran G J Biomol Struct Dyn; 2022; 40(21):11320-11338. PubMed ID: 34463213 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]